Results for tag: "Personalized Medicine Biomarkers"

The Personalized Medicine Biomarkers market is a subset of the biotechnology industry that focuses on the development and use of biomarkers to identify and treat diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Personalized medicine biomarkers are used to tailor treatments to individual patients, based on their genetic makeup and other factors. The personalized medicine biomarkers market is driven by the increasing prevalence of chronic diseases, such as cancer, and the need for more effective treatments. The market is also driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective biomarkers. Companies in the personalized medicine biomarkers market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more